SPSabina Palma

Sabina Palma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sabina Palma has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrated genomic and functional characterization of a BI/NAP1/027 Clostridioides difficile strain reveals traits associated with persistence and virulence

    by Angela María Barbero, Sabina Palma, Laureano A. Español, Miranda Palumbo, María del Mar Agosti, Nicolás Diego Moriconi, Agostina de María, María Belén Cieri, Federico Serral, Diego Ruggeri, et al.

    Objectives: Hypervirulent BI/NAP1/027 strains of Clostridioides difficile have been associated with increased incidence, severity, and recurrence of C. difficile infection (CDI). This study aimed to perform a genomic and functional characterization of a BI/NAP1/027 strain (CDC20121308) to validate its use in C. difficile pathogenesis models.Methods: Whole-genome sequencing and comparative genomic analyses were performed to identify genetic determinants associated with virulence and antimicrobial resistance. Phenotypic assays assessed antibiotic susceptibility, motility, and biofilm formation. The pathogenic potential of CDC20121308 was evaluated through its interaction with enterocytes cell line and immune innate cells, as well as disease development in a murine infection model.Results: Whole-genome sequencing identified 3,717 coding sequences and 45 tRNAs, with approximately 26% of coding sequences assigned to RAST subsystems. Genome analysis revealed determinants associated with resistance to toxic compounds and antibiotics, including genes linked to vancomycin and tetracycline resistance, which was confirmed phenotypically. CDC20121308 also displayed a motile phenotype, formed biofilms, and carried a genomic region encoding components of a type IV secretion system. The strain induced marked cytotoxicity in Caco-2 monolayers, promoted severe intestinal pathology, and triggered pro-inflammatory responses in human innate immune cells.Conclusions: CDC20121308 retains the genomic and phenotypic traits associated with hypervirulent BI/NAP1/027 lineages, including antimicrobial resistance, motility, biofilm formation, and marked pathogenic potential. These findings support its use as a relevant experimental model for studying CDI pathogenesis and host-pathogen interactions.

  • Open Access

    Epidemiology of Clostridioides difficile Infection in Argentina and Associated Risk Factors Evaluated Through a Meta-Analysis

    by Angela María Barbero, Nicolás Diego Moriconi, Sabina Palma, Josefina Celano, María Gracia Balbi, Lorenzo Sebastián Morro, María Martina Calvo Zarlenga, Jorgelina Suárez, María Guadalupe Martínez, Mónica Graciela Machain, et al.

    Background: Clostridioides difficile is classified within the first 18 threats for antimicrobial resistance and is the leading cause of hospital-acquired enteric infection. Community-associated cases have notably increased in recent decades, highlighting that accurate and up-to-date statistics characterizing the epidemiology of C. difficile infection (CDI) are critical. Methods: We conducted a retrospective (2019–2023) case-control study evaluating the prevalence of CDI in 249 stool samples from hospitalized patients in the sanitary region III of Buenos Aires, Argentina. The presence of C. difficile was detected by combining EIA, PCR, and toxigenic culture via a diagnostic algorithm. Clinical and demographic data from patients were analyzed to identify CDI-associated risk factors. We also conducted a systematic review and a meta-analysis contrasting our results with 38 studies selected from different countries. Results: One in five patients presented C. difficile as the etiological agent of diarrhea. Eighty percent of the CDI+ cases carried toxigenic strains, with a third of cases associated with community environments. Age ≥ 69 years, previous use of antibiotics, previous hospitalization, and previous episodes of CDI emerged as predisposing factors for CDI in our study cohort. In an exploratory evaluation of clinical data, CDI+ patients showed higher leukocytes and platelets counts, a decreased basophil count, and increased urea concentration. At the global level, the meta-analysis reinforced advanced age, previous consumption of antibiotics, previous consumption of proton pump inhibitors, previous hospitalization, and previous CDI as risk factors for CDI. Conclusions: These results emphasize the importance of continued epidemiological surveillance of CDI. Our findings confirm previously described risk factors, both in our cohort and at the global level. Exploratory alterations in laboratory parameters were observed, although their clinical relevance and specificity require further investigation.